|
Henarejos-Escudero P, Hernandez-Garcia S, Guerrero-Rubio MA, Garcia-Carmona F, Gandia-Herrero F. Antitumoral Drug Potential of Tryptophan-Betaxanthin and Related Plant Betalains in the Caenorhabditis elegans Tumoral Model. Antioxidants (Basel). 2020 Jul 22;9(8):646. doi: 10.3390/antiox9080646. PubMed PMID: 32707947; PubMed Central PMCID: PMC7465535.
AÑO: 2020; IF: 6.312
|
|
Guerrero-Rubio MA, Hernandez-Garcia S, Escribano J, Jimenez-Atienzar M, Cabanes J, Garcia-Carmona F, Gandia-Herrero F. Betalain health-promoting effects after ingestion in Caenorhabditis elegans are mediated by DAF-16/FOXO and SKN-1/Nrf2 transcription factors. Food Chem. 2020 Nov 15;330:127228. doi: 10.1016/j.foodchem.2020.127228. Epub 2020 Jun 5. PubMed PMID: 32535316.
AÑO: 2020; IF: 7.514
|
|
Ortega, E; Ballester, FJ; Hernandez-Garcia, A; Hernandez-Garcia, S; Guerrero-Rubio, MA; Bautista, D; Santana, MD; Gandia-Herrero, F; Ruiz, J. Novel organo-osmium(ii) proteosynthesis inhibitors active against human ovarian cancer cells reduce gonad tumor growth in Caenorhabditis elegans. INORGANIC CHEMISTRY FRONTIERS. 2021; 8(1):141-155. 10.1039/c9qi01704f
AÑO: 2021; IF: 7.779
|
|
Gea-Gonzalez A, Hernandez-Garcia S, Henarejos-Escudero P, Martinez-Rodriguez P, Garcia-Carmona F, Gandia-Herrero F. Polyphenols from traditional Chinese medicine and Mediterranean diet are effective against Abeta toxicity in vitro and in vivo in Caenorhabditis elegans. Food Funct. 2022 Feb 7;13(3):1206-1217. doi: 10.1039/d1fo02147h. PubMed PMID: 35018947.
AÑO: 2022; IF: 6.1
|
|
Ortega-Forte E, Hernandez-Garcia S, Vigueras G, Henarejos-Escudero P, Cutillas N, Ruiz J, Gandia-Herrero F. Potent anticancer activity of a novel iridium metallodrug via oncosis. Cell Mol Life Sci. 2022 Sep 6;79(10):510. doi: 10.1007/s00018-022-04526-5. PubMed PMID: 36066676; PubMed Central PMCID: PMC9448686.
AÑO: 2022; IF: 8.0
|